Drug Information

Drug General Information
Drug ID
D0D3XM
Former ID
DIB010466
Drug Name
TAK-137
Indication Psychiatric disorder [ICD9: 290-319; ICD10:F01-F99] Phase 1 [524799]
Target and Pathway
Target(s) Glutamate receptor AMPA subtype Target Info Modulator [551871]
References
Ref 524799ClinicalTrials.gov (NCT02163915) Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder. U.S. National Institutes of Health.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.